Current position:Home >Product >
N-[2,5-bis(oxidanylidene)-1-(4-sulfamoylphenyl)pyrrolidin-3-yl]-N-cycloheptyl-adamantane-1-carboxamide
N-[2,5-bis(oxidanylidene)-1-(4-sulfamoylphenyl)pyrrolidin-3-yl]-N-cycloheptyl-adamantane-1-carboxamide
|
|
Canonical SMILES:
C1CCCC(CC1)N(C2CC(=O)N(C2=O)C3=CC=C(C=C3)S(=O)(=O)N)C(=O)C45CC6CC(C4)CC(C6)C5
Isomeric SMILES
C1CCCC(CC1)N(C2CC(=O)N(C2=O)C3=CC=C(C=C3)S(=O)(=O)N)C(=O)C45CC6CC(C4)CC(C6)C5
InChI
InChI=1S/C28H37N3O5S/c29-37(35,36)23-9-7-22(8-10-23)31-25(32)14-24(26(31)33)30(21-5-3-1-2-4-6-21)27(34)28-15-18-11-19(16-28)13-20(12-18)17-28/h7-10,18-21,24H,1-6,11-17H2,(H2,29,35,36)
Other Product
- 2,5-bis(chloranyl)cyclohexa-2,5-diene-1,4-diol
- 2,5-bis(chloranyl)benzene-1,4-diol
- 2,5-bis(chloranyl)phenol
- 2-oxidanylidenehexanedioic acid
- 2-oxidanylidene-3-sulfanyl-propanoic acid
- 3-oxidanylbenzaldehyde
- 3-azanylpropanal
- 2-azanyl-3-oxidanyl-benzoic acid
- 3-(3-hydroxyphenyl)propanoic acid
- 3-oxidanylidenehexanedioic acid
- 2-(1,3-benzoxazol-2-ylsulfanyl)-N-[4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl]propanamide
- N-[2,5-bis(oxidanylidene)-1-(4-sulfamoylphenyl)pyrrolidin-3-yl]-N-[2-(3-chlorophenyl)ethyl]adamantane-1-carboxamide
- N-[4-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfamoyl]phenyl]-2-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]propanamide
- N-[2,5-bis(oxidanylidene)-1-(4-sulfamoylphenyl)pyrrolidin-3-yl]-N-(1-phenylethyl)adamantane-1-carboxamide
- 2-(1-methylimidazol-2-yl)sulfanyl-N-[4-[(5-methyl-1,2-oxazol-3-yl)sulfamoyl]phenyl]propanamide
- N-[2,5-bis(oxidanylidene)-1-(4-sulfamoylphenyl)pyrrolidin-3-yl]-N-(pyridin-3-ylmethyl)adamantane-1-carboxamide
- 2-(3-methyl-4-oxidanylidene-quinazolin-2-yl)sulfanyl-N-[4-(pyrimidin-2-ylsulfamoyl)phenyl]propanamide
- N-[1-(4-bromophenyl)-2,5-bis(oxidanylidene)pyrrolidin-3-yl]-N-[2-(4-sulfamoylphenyl)ethyl]adamantane-1-carboxamide
- 2-(4-oxidanylidene-3-phenyl-quinazolin-2-yl)sulfanyl-N-[4-(pyrimidin-2-ylsulfamoyl)phenyl]propanamide
- 2,2,3,3-tetramethyl-N-[4-[(4-methylpyrimidin-2-yl)sulfamoyl]phenyl]cyclopropane-1-carboxamide

